Effects of allopurinol on PG-LPS-induced phospho-CaMKII by Akinaka Morii (12709672)

Subjects:

Schematic diagram of the experimental workflow. by Bhuripit Saraphol (20855573)

Subjects:

Normality test using the Shapiro-Wilk test. by Akinaka Morii (12709672)

Subjects:

Results of RF algorithm screening factors. by Jintao Li (448681)

“…For instance, the RF-MLPR model achieved a 3.7%–6.5% improvement in the Nash-Sutcliffe efficiency (NSE) metric across four hydrological stations compared to the RF-SVR model. (4) Prediction accuracy decreased with longer forecast periods, with the R² value dropping from 0.8886 for a 1-month forecast to 0.6358 for a 12-month forecast, indicating the increasing challenge of long-term predictions due to greater uncertainty and the accumulation of influencing factors over time. (5) The RF-MLPR model outperformed the RF-SVR model, demonstrating a superior ability to capture the complex, nonlinear relationships inherent in the data. …”

P values of Kruskal–Wallis test at 95% significance level. by Fahd Saeed Alakbari (10701871)

Subjects:

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... by Felix Alexandre Schoeller (20988295)

Subjects:

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. by Hala Tamim El Jarkass (16625309)

Subjects:

Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. by Mucahit Gemici (21519313)

One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. by Mucahit Gemici (21519313)

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects: